Feedback / Questions
foralumab nasal (TZLS-401 nasal) - Tiziana Life Sci
https://www.globenewswire.com/news-release/2025/08/14/3133472/0/en/Tiziana-Life-Sciences-Doses-First-Patient-in-Phase-2a-Trial-of-Intranasal-Foralumab-for-Multiple-System-Atrophy.html
Aug 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next